Natural killer (NK) cells are specialized lymphocytes with the innate ability to eliminate virally infected and cancerous cells, but the mechanisms that control NK cell development and cytotoxicity are incompletely understood. We identified novel roles for Sclerostin domain containing-1 (Sostdc1) in NK cell development and function. Sostdc1knockout (Sostdc1 -/-) mice display a progressive accumulation of transitional NK cells (CD27 + CD11b + , tNK) with age, indicating a partial developmental block. The Ly49 repertoire on NK cells in Sostdc1 -/mice is also changed. Lower frequencies of Sostdc1 -/splenic tNKs express inhibitory Ly49G2 receptors, but higher frequencies express activating Ly49H and Ly49D receptors. However, the frequencies of Ly49I + , G2 + , H + and D + populations were universally decreased at the most mature (CD27 -CD11b + , mNK) stage. We hypothesized that the Ly49 repertoire in Sostdc1 -/mice would correlate with NK killing ability, and observed that Sostdc1 -/-NK cells are hyporesponsive against MHC-I-deficient cell targets in vitro and in vivo, despite higher CD107a surface levels and similar IFN expression to controls. Consistent with Sostdc1's known role in the regulation of Wnt signaling, high levels of Wnt coactivators Tcf7 and Lef1 were observed in Sostdc1 -/-NK cells. Expression of the NK development gene Id2 was decreased in Sostdc1 -/-iNK and tNK cells, but we observed no changes in Eomes and Tbx21 expression. Reciprocal bone marrow transplant experiments showed that Sostdc1 regulates NK cell maturation and expression of Ly49 receptors in a cellextrinsic fashion from both non-hematopoietic and hematopoietic sources. Taken together, these data support a role for Sostdc1 in the regulation of NK cell maturation, and NK cell cytotoxicity, and identify potential NK cell niches.
Summary of Results
• Sostdc1 -/mice display a partial block between the tNK and mNK developmental stages.
• Sostdc1 influences the Ly49 receptor repertoire on NK cells.
• NK cells in Sostdc1 -/mice display impaired ability to kill 2m -/target cells.
• Sostdc1 -/-NK cell subsets express high levels of Wnt coactivators Tcf7 and Lef1.
• Id2 expression is decreased in iNK and tNK cells in the absence of Sostdc1.
• Bone marrow transplantation experiments demonstrate cell-extrinsic regulation of NK cell maturation by Sostdc1 in both non-hematopoietic (stromal) and hematopoietic cells.
Background and Rationale 1
Natural Killer (NK) cells are innate lymphocytes that are important for early 2 immune defense against tumors and virally infected cells. Since the initial discovery of 3 NK cells in 1975, studies from many groups have identified NK cell receptors that are 4 involved in self/non-self recognition, NK cell precursors and stages of maturation, 5 cytokines and transcription factors that are critical for NK cell development and function, 6
and evidence for NK cell immune memory [1] [2] [3] [4] [5] [6] [7] [8] [9] . Despite over 40 years of NK cell history, 7 the molecular and cellular mechanisms that drive and integrate these processes is still 8 unclear. In particular, how the microenvironment regulates NK cell maturation and 9 function is still an area of ongoing investigation. 10
Conventional NK cells develop in the bone marrow (BM) from hematopoietic 11 stem cells (HSCs) following a well-established sequence of maturational stages and 12 egress to the peripheral organs to fully mature and function 10, 11, 12 . NK cell maturation 13 ( Figure 1A) originates with the immature NK (CD27 + CD11b -, iNK) cells, which 14 progresses to the transitional NK cell stage (CD27 + CD11b + , tNK), then to the final 15 mature stage (CD27 -CD11b + , mNK) [13] [14] [15] [16] . As NK cells progress through these stages, 16 they lose proliferative and cytokine-producing capability, but gain cytotoxic ability 17 against target cells 12, 17, 18 . Although the BM microenvironment is critical for NK cell 18 development, how the peripheral microenvironment regulates NK cell maturation and 19 cytotoxicity is incompletely understood and requires further investigation. 20
Sclerostin domain containing-1 (Sostdc1), also known as Wise, Ectodin, Usag-1, 21
and Sost-like, has been studied in the context of tooth development, kidney disease, 22 hair follicle formation, and bone fracture [19] [20] [21] [22] [23] [24] [25] . Sostdc1 can function as an antagonist of 23 both Bone Morphogenetic Protein (BMP) and canonical Wnt signaling pathways 20, 21, 23 . 24 Sostdc1 expression is highly expressed in skin, brain, and intestine, as well as in 25 skeletal muscles, kidney, lungs, and vasculature 20, 22, 23 . Most recently, we found it also 26 to be expressed in the bone periosteum and mesenchymal stem cells (MSCs) to 27 support bone formation and fracture remodeling 26 . Here, we reveal Sostdc1's cell-28 extrinsic roles in the regulation of NK cell maturation, Ly49 receptor expression and 29 cytotoxic function in the BM and spleen. 30
Results 31
Sostdc1 -/mice display a partial block at the tNK stage 32
Our previous studies demonstrated that femurs of Sostdc1 -/mice display a 21 33 percent increase in BM cavity volume compared to WT controls 26 . Consistent with this, 34 the total BM cellularity of Sostdc1 -/bones was increased (Figure 1B) . Sostdc1 -/mice 35 also displayed higher total splenic cell numbers ( Figure 1C) . The increased cellularity 36 suggested that the Sostdc1 -/-BM and spleen microenvironments may be altered, and 37 that immune cell development may also be affected by the loss of Sostdc1. To test this, 38
we performed flow cytometry (FCM) and observed no differences in frequencies or 39 absolute numbers of CD19 + B lymphocytes, CD3 + T lymphocytes, and CD11b + Gr1 + 40 granulocytes (data not shown). However, the frequency of CD11b + Gr1cells in the 41 Sostdc1 -/spleen was reduced. To determine if the CD11b + Gr1cells were monocytes 42 or NK cells, we performed more detailed analysis with anti-NK1.1. Total NK (Live, CD3 -43 ,CD19-,Gr1 -,NK1.1 + ) frequencies were not affected, but total NK cell numbers were 44 increased only in the BM of Sostdc1 -/mice (Figure 1D-1G ). We then investigated if lack 45 of Sostdc1 affected NK cell maturation ( Figure 1A) , and discovered that Sostdc1 -/mice 46 exhibit a partial block between the tNK (NK1.1 + CD11b + CD27 + ) and mNK (NK1.1 + 47 CD11b + CD27 -) cell stages in both the BM and spleen, as demonstrated by the increase 48 in frequency and number of tNK cells in the BM (Figures 1H and 1I ) and spleen 49 ( Figures 1J and 1K) , and the decreased frequency of mNKs in the spleen. These data 50 indicated that Sostdc1 is required for full developmental progression from the tNK to the 51 mNK cell stages. 52
53

Absence of Sostdc1 alters the Ly49 receptor repertoire on NK cells 54
We also examined if NK cells in Sostdc1 -/mice expressed different levels and 55 distributions of inhibitory (Ly49I and Ly49G2) and activating (Ly49D and Ly49H) Ly49 56 receptors. FCM analysis of the Ly49 repertoire on iNKs, tNKs, and mNKs in Sostdc1 -/-57 mice revealed decreased frequencies of Ly49G2 + cells at all NK cell stages in the BM 58 Figure 1A-1C ) and spleen (Figure 1L-1N) . In contrast, frequencies of 59 Ly49H + iNK and tNK cells in the Sostdc1 -/-BM and spleen were higher than controls, but 60 the frequencies of Ly49H + mNK cells were reduced in both tissues (although only 61 statistically significant in the spleen). Similarly, frequencies of Ly49D + in iNK and tNK 62 cells were increased and reduced amongst the mNKs in the Sostdc1 -/-BM and spleen 63 ( Figure 1L-1N and Supplemental Figure 1A-1C ). The frequencies of Ly49I + in iNK 64 and tNK cells were similar to controls, but frequencies of Ly49I + mNK cells were 65 decreased in Sostdc1 -/mice ( Figure 1N Since it is theorized that NK cell activity is governed by the combined set of Ly49 70 receptors expressed on a given NK cell, we further compared the frequencies of WT 71
(Supplemental
and Sostdc1 -/-NK cells that express different combinations of Ly49 receptors 27 72 (Supplemental Figure 2) . Higher frequencies of iNK and tNK cells expressing more 73 activating than inhibitory receptors (i.e. "activating repertoires") were observed in 74 Sostdc1 -/mice (Supplemental Figure 2D and 2E) . However, lower frequencies of 75 mNK cells with activating repertoires were observed (Supplemental Figure 2F) . Taken 76 together, these data show the lack of Sostdc1 influences the Ly49 receptor repertoire. 77 78 NK cells in Sostdc1 -/mice are impaired in their ability to kill 2m-deficient targets 79
The reduced frequency of splenic mNK with "activating repertoires" that favored 80 activation suggested that NK cell cytotoxicity in Sostdc1 -/mice would be impaired. To hours of target cell challenge, we quantified the remaining β2m -/-, WT (β2m +/+ ) and 92 Sostdc1 -/-(β2m +/+ ) targets by FCM, to determine the frequency of live cells in each target 93 population (Figure 2A, 2C and 2D) , and calculated the ratio of WT (β2m +/+ ), Sostdc1 -/-94 (β2m +/+ ), and β2m -/targets in each setting ( Figure 2E ). An increased proportion of β2m -95 /targets remained in the Sostdc1 -/mice compared to WT controls (Figure 2E) . We 96 confirmed that there was no effect on fluorophore labeling on β2m -/cell target killing 97 with reciprocal labeling of targets of opposing fluorophore (Figure 2C and 2D) . Thus, 98 these results demonstrated that NK cells in Sostdc1 -/mice have impaired killing ability 99 (Figure 2E) . 100
This result was confirmed using an in vitro NK cell killing assay (Supplemental 101 Figure 3 ) using enriched NK cells from Sostdc1 -/and WT mice 30 , challenged with 102 fluorescently labeled β2m -/or β2m +/+ targets for 4 hours, in effector to target (E:T) ratios 103 of 1:1, 2:1, and 4:1 (Supplemental Figure 3A-3C ). As expected, WT NK and Sostdc1 -/-104 NK cells did not lyse β2m +/+ targets at any E:T ratio (Supplemental Figure 3D ). 105
However, as shown in Supplemental Figure 3E , Sostdc1 -/-NK cells have reduced 106 capacity to lyse β2m -/targets, even at the highest 4:1 E:T ratio, indicating their 107 hyporesponsiveness to β2m -/targets. FCM analysis of Sostdc1 -/-NK cells to produce 108 the cytokine IFN after stimulation revealed comparable levels to WT controls 109 (Supplemental Figure 3F and 3G) . Surprisingly, activated Sostdc1 -/-NK cells at all 110 developmental stages expressed significantly increased levels of the degranulation 111 marker CD107a (Supplemental Figure 3H and 3I) . Taken together, these results 112 suggest that Sostdc1 -/-NK cell cytotoxicity is impaired, despite their ability to produce 113 comparable levels of IFN and evidence of elevated accumulation of cytotoxic granules 114 at the cell surface. 115 116
Sostdc1-KO NK cell subsets upregulate Wnt genes Tcf7 and Lef1 117
Given that Sostdc1 is a known antagonist to canonical Wnt signaling, we 118 hypothesized that expression of canonical Wnt pathway transcription factors would be 119 increased in Sostdc1 -/-NK cell subsets. We purified iNK, tNK, and mNK cells by FCM 120 and analyzed expression of Wnt pathway genes Tcf7 3,31 , Lef1 32 , Axin2 33 and Myc 34 , by 121 real-time quantitative polymerase chain reaction (qPCR). Our results showed that 122 relative to WT subsets, Sostdc1 -/splenic tNK and mNK cells express significantly higher 123 levels of Tcf7, and tNK cells also show significantly increased expression of Lef1 124 ( Figure 3A) , consistent our hypothesis. Alternatively, we did not observe an increase in 125
Axin2 and Myc expression in any Sostdc1 -/-NK cell subsets ( Figure 3A ). Together, 126 these results support a role for Wnt signaling by Tcf7 and Lef1 in NK cells of Sostdc1 -/-127 mice. 128
We also analyzed expression of transcription factors that govern NK cell 129 maturation. T-box family members, Eomesodermin (Eomes) and T-box protein 21 130 (Tbx21), have been shown to play a crucial role in early immature and mature NK cell 131 maturation 35, 36 . Additionally, Eomes-deficient NK cells have reduced Ly49A, Ly49D, 132
Ly49G2, and Ly49H frequencies 35 . Inhibitor of DNA-binding 2 (Id2) is an early TF 133 involved in NK and innate lymphoid cell (ILC) lineage commitment 36, 37, 38 . Id2-deficient 134 mice have fewer mature NK cells and impaired cell killing in vitro 39 . Since Sostdc1 -/-135 mice display a partial maturation block at the tNK cell stage and altered Ly49 receptor 136 frequencies (Figure 1) , we hypothesized that we would observe decreased expression 137 of Eomes, Tbx21, and Id2 at distinct NK cell stages [35] [36] [37] [38] [39] [40] [41] [42] . We found Id2 expression was 138 decreased in iNK and tNK cells in Sostdc1 -/mice ( Figure 3B) Figure 4C-4E) , similar to the 154 phenotype that was observed in the non-transplanted Sostdc1 -/mice (Figure 1H-1K) . 155
Ly49H + mNK cells were decreased in WT→KO, similar to non-transplanted Sostdc1 -/-156 mice in the spleen ( Figure 4F and Figure 1N ). In contrast, WT→KO chimeras 157 contained decreased frequencies of splenic Ly49H + iNK and tNK cells compared to 158 WT→WT controls, a result that was the opposite of the increased frequencies of Ly49H + 159 cells within these NK subsets of non-transplanted Sostdc1 -/mice ( Figure 4F and 160 Figure 1L-1M ). In addition, no differences in Ly49G2 and Ly49D subsets were 161 observed between the WT→KO and control chimeras, a result that also differed from 162 the non-transplanted Sostdc1 -/mice in the spleen (Figure 4F and Figure 1L-1N) and 163 BM (Supplemental Figure 4F) . Taken together, these results suggested that Sostdc1 164 in non-hematopoietic cells controls progression from tNK to mNK stages and NK 165 cellularity, but plays a smaller role in shaping the Ly49 receptor repertoire. 166
Sostdc1 in a hematopoietic cell lineage other than NK cells regulates the Ly49 receptor 167
repertoire 168
We next prepared reciprocal KO→WT chimeras (whole BM cells from Sostdc1 -/-169 (CD45.2 + /5.2 + ) donors transplanted into lethally irradiated WT (CD45.1 + /5.1 + ) recipient 170 mice) to determine how Sostdc1 -/-NK cells mature and if their Ly49 receptor frequency 171 was changed in a Sostdc1-sufficient microenvironment (Figure 5A) . Remarkably, 172 splenic NK cell numbers ( Figure 5B ) and maturation ( Figure 5C-5E) were not affected 173 in KO→WT chimeras, in contrast to the non-transplanted Sostdc1 -/mice and the 174 WT→KO chimeras ( Figure 1H-1I and Figure 4B-4E, respectively) . However, the BM 175 analysis showed an increase in NK cell numbers (Supplemental Figure 4H ) and a 176 similar tNK cell accumulation as observed in the non-transplanted Sostdc1 -/mice 177 ( Figure 1H-1K and Supplemental Figure 4K ). Furthermore, analysis of donor-derived 178
Ly49-expressing NK cell subsets in the spleens in KO→WT chimeras demonstrated 179 some similar patterns as non-transplanted Sostdc1 -/mice, such as the increase in 180 frequencies of Ly49H + and Ly49D + tNK cells and a decrease in the frequencies of 181 Ly49G2 + iNK cells, and decreased frequencies of Ly49G2 + and Ly49I + mNK cells 182 ( Figure 5F and Figure 1L-1N) . However, higher frequencies of mNK cells expressing 183
Ly49H and Ly49D were observed in the KO→WT spleens, whereas these populations 184
were decreased in non-transplanted Sostdc1 -/mice ( Figure 5F and Figure 1L-1N) . 185
The Ly49 frequency patterns observed in the KO→WT chimeras strongly 186 suggested that Sostdc1 in NK cells regulated the Ly49 repertoire in a cell-intrinsic 187 fashion. To confirm this, we examined Sostdc1 expression in sorted WT iNK, tNK, and 188 mNK cells by qPCR. Surprisingly, iNK, tNK, and mNK cells do not express Sostdc1 189 granulocytes, which were all negative for Sostdc1 ( Figure 5G) . Only CD4 + and CD8 + T 193 cells displayed high levels of Sostdc1 expression (Figure 5G) . This expression pattern 194 was confirmed in CD4 and CD8 T cells from Sostdc1 -/mice using PCR for LacZ 26 (data 195 not shown). Collectively, these results indicate that Sostdc1 does not regulate splenic 196 NK cell development in a NK cell-intrinsic manner, and identifies Sostdc1-positive T 197 cells as putative NK niche cells that may contribute to shaping of the Ly49 repertoire. 198
Discussion
We have uncovered novel roles of the Sostdc1 gene in NK cell maturation and 199 function through two distinct mechanisms. Our working model is illustrated in Figure 6 . 200
Our data supports that Sostdc1 from two distinct sources, non-hematopoietic stromal 201 cells, and hematopoietic cells (in particular, CD4 + and CD8 + T lymphocytes) regulate NK 202 cell maturation versus Ly49 receptor expression and frequencies, respectively, in 203 somewhat independent manners, and that this occurs through the control of Wnt 204 signaling activation. Our developmental and functional NK cytotoxicity assay results 205 lead us to conclude several NK "niche cell" populations exist that require Sostdc1 206 expression in order to produce a healthy NK cell repertoire that can distinguish between 207 self and non-self. 208
Perhaps the most surprising finding from our studies is that Sostdc1 is not 209 expressed in NK cells themselves, and that Ly49 receptor expression in the spleen is 210 possibly controlled in a cell-extrinsic manner by CD4 + and CD8 + T cells. To our 211 knowledge, there is no previous demonstration of NK and T cell crosstalk that shapes 212 the NK Ly49 receptor profile. Recent studies have defined Sostdc1 as a marker of 213 relatively rare memory PD-1 + CD4 + T cells 43,44 and T follicular helper (TFH) cells found in 214 the Peyer's Patches and peripheral lymph nodes 10 , but only cite Sostdc1's role on 215 humoral immunity. We observed high expression of Sostdc1 in bulk sorted splenic 216 CD4 + and CD8 + cells from the spleen, and we assume that most of the Sostdc1 217 expression is coming from PD1 + CD4 + T cells and TFH cell subsets, based on these 218 published studies. We have not observed any obvious block in T cell development in 219
the Sostdc1 -/mice (data not shown). Undeniably, further experimentation is required to 220 definitively connect the role of these T cell subsets in NK cell regulation, and to 221 determine whether the T cells are regulating Ly49 receptor expression via directly 222 binding to NK cells, or mediating their effects indirectly by secreting Sostdc1 in a 223 paracrine fashion. 224
Wnt signaling has been well studied in the framework of hematopoietic stem cells 225 (HSCs) to help promote proliferation, differentiation, and homeostasis 45, 46 . It is now 226 evident that canonical Wnt signaling plays a crucial role in the regulation of many Based on our current findings, we cannot rule out whether the impaired killing of 240 β2m -/targets by NK cells from Sostdc1 -/mice is due to insufficient numbers of mNK 241 cells, inefficient execution of the perforin and granzyme pathways, the dysregulation of 242
Ly49 receptor frequencies amongst NK cells, or a combination of all of these possible 243 mechanisms. NK cells at tNK and mNK stages express genes involved in cytotoxic 244 function 15, 11, 12 . It has been shown that Ly49 receptor expression is required for NK cell 245 cytoxicity 47 , which is consistent with our observations that the splenic mNK cells in the 246 Sostdc1 -/mice contain decreased frequencies of all Ly49-expressing subsets and the 247 killing ability of Sostdc1 -/-NK cells towards β2m -/targets is poor. Because Sostdc1 -/-248 mice express increased proportions of tNK cells with an "activating" repertoire 48 and 249 high CD107a levels, we would have expected enhanced target cell killing by the 250 Sostdc1 -/-NK cells, but we observed them to be hyporesponsive. Taken together, our 251 results suggest that NK cell cytotoxicity is universally disabled in the absence of 252
Sostdc1, but is caused by distinct mechanisms in tNK and mNK cells. Further 253 experiments, in which the killing ability of purified tNK and mNK cells from Sostdc1 -/-254 mice is specifically examined, are necessary to definitely demonstrate this. Additional 255 work is also needed to dissect the specific roles of non-hematopoietic and 256 hematopoietic cells on NK cell cytotoxicity. Understanding the details of the basic 257 biology underlying the development and regulation of NK cell cytotoxicity and how these 258 processes are quantitatively integrated could be applied to manipulate these processes 259 in a controlled fashion in order to produce specific numbers of NK cells with enhanced 260 killing ability, and perhaps impact the production of NK cell-based cancer 261 immunotherapies 1-6 . 262 
Figure Legends
In vivo NK cell killing assay 370
Sostdc1 -/and B6 control mice received 200 µg of polyinosinic-polycytidylic acid 371 (Poly(I:C)) (Sigma-Aldrich) via injection into the intraperitoneal cavity. Thirty-six hours 372 later, splenic cells from aged and sex-matched β2m -/and β2m +/+ (WT or Sostdc1 -/-) mice 373 were harvested and processed to a single cell suspension in media (Medium 199, 2% 374 FCS, 2mM L-glutamine, 100U/ml penicillin, 100 µg/ml streptomycin, 25 mM HEPES) 375 and counted using a hemocytometer. β2m +/+ (WT or Sostdc1 -/-) and β2m -/control target 376 cells were stained with anti-CD45 conjugated to either APC or PE in media for 20 min 377 on ice. 5x10 6 β2m -/stained splenic cells were mixed with 5x10 6 β2m +/+ stained control 378 cells at a 50:50 ratio, thus providing a method to track each target cell type by flow 379 cytometry. Stained cell target cell mixtures were injected intravenously by retro-orbital 380 injection. Fourteen hours later, spleens from Sostdc1 -/and WT recipients were then 381 harvested and processed for flow cytometry. NK cell lysis of targets was determined by 382 flow cytometry (FCM) and calculated by the ratio of live β2m +/+ (WT), β2m +/+ (Sostdc1 -/-) 383 and β2m -/targets over WT control cells in the same mouse. 384 385
Gene expression analysis by quantitative PCR 386
Cells were pelleted and resuspended in RNeasy Lysis Buffer with 2-387 mercaptoethanol (Qiagen). Total RNA was purified using Qiagen RNeasy Mini Kit 388 (Qiagen) according to manufacturer's protocol. RNA concentration and purity was 389 analyzed using a NanoDrop ND-1000 Spectrophotometer (Thermo Fisher Scientific). 390 iScript cDNA Synthesis Kit was used (Bio-Rad Laboratories) according to the 391 manufacturer's protocol. Real-time quantitative PCR performed using the iTaq Universal 392 SYBR Green Supermix kit (Bio-Rad Laboratories) and ran on a Stratagene Mx3000P 393 thermocycler (Thermo Fisher Scientific) using the following conditions: 1 cycle at 9°C for 394 30 s, followed by 40 cycles of 95°C for 5 s and 60°C for 30 s, and a final cycle at 95°C 395 for 1 min, 55°C for 30 s, and 95°C for 30 s to end the run. The PCR products were 396 visualized on a 2% agarose gel and imaged under UV light using a ChemiDoc (Bio-Rad 397 Laboratories) with SYBR Safe (Invitrogen) stain. The list of genes and their primer 398 sequences are listed in Supplementary Table 1 . 399
Bone marrow chimeras 400
Whole BM cells were aseptically isolated from B6 (CD45.1 or CD45.2) wild type 401 (WT) or Sostdc1 -/-(CD45.2) mice and 5x10 6 cells were transferred via retro-orbital 402 injection into lethally (10 Gy) irradiated recipients 4 hours after irradiation using a 403 cesium irradiator. Mice were given neomycin-containing drinking water for 2 weeks 404 post-transfer. Chimeras were analyzed 14 weeks post-transplant. 405 406
